NMD bags €38M to run orphan neuromuscular disease trials | FierceBiotech
Tunge pengetanke klar til nye investeringer i biotekselskab fra Aarhus
NMD Pharma company information, funding & investors | Dealroom.co
NMD Pharma
Roel Bulthuis - Director at NMD Pharma | The Org
NMD Pharma - PIR International
Labiotech.eu on Twitter: "NMD Pharma, from @AarhusUni, is willing to tackle Neuromuscular Transmission Disorders #BioEquity2016… "
NMD Pharma company information, funding & investors | Dealroom.co
Denmark in New York on Twitter: "#DKBIO17 is "a great opportunity for us to broaden our scope and look for investors.” - Thomas H. Pedersen, CEO, NMD Pharma… https://t.co/AUeO5JqgX6"
Management — NMD Pharma
NMD Pharma, finalist i Life Sciences kategorien - EY Danmark
Big deal: NMD flexes series A muscles - Global University Venturing
NMD Pharma - Capnova
Company Presentation
Investors — NMD Pharma
Management — NMD Pharma
Company Presentation
NMD Pharma company information, funding & investors | Dealroom.co
NMD Pharma Receives Approval to Start a combined Phase I/IIa Clinical Trial of NMD670 for the Treatment of Symptoms of Myasthenia Gravis
NMD Pharma is Strengthening Muscles in Neuromuscular Disorders
Prominent Canadian researcher in Denmark: Why I left a top job in California
NMD Pharma — NMD Pharma
NMD Pharma company information, funding & investors | Dealroom.co
NMD Pharma begins first clinical trial: "Our entire team can be enormously proud"
